Evidence map›Paper›PMID 31164075›Full record

ArticleJournal of the Royal Society, Interface2019

An electro-osmotic microfluidic system to characterize cancer cell migration under confinement.

T H Hui, W C Cho, H W Fong, M Yu, K W Kwan, K C Ngan, K H Wong, Y Tan, S Yao, H Jiang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Aquaporin 5 expression regulates MDA-MB-231 spheroid multicellular invasion.American journal of physiology. Cell physiology · 2025
    Article
  2. Article
  3. Review
  4. The multifaceted role of aquaporins in physiological cell migration.American journal of physiology. Cell physiology · 2023
    Review
  5. Aquaporin-mediated dysregulation of cell migration in disease states.Cellular and molecular life sciences : CMLS · 2023
    Review
  6. Methods for studying mammalian aquaporin biology.Biology methods & protocols · 2023
    Review
  7. Aquaporins in Tumor.Advances in experimental medicine and biology · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

T H Hui1 Department of Mechanical Engineering, The University of Hong Kong , Hong Kong SAR , People's Republic of China.
W C Cho2 Department of Clinical Oncology, Queen Elizabeth Hospital , Hong Kong SAR , People's Republic of China.
H W Fong2 Department of Clinical Oncology, Queen Elizabeth Hospital , Hong Kong SAR , People's Republic of China.
M Yu3 Department of Mechanical and Aerospace Engineering, Hong Kong University of Science and Technology , Hong Kong SAR , People's Republic of China.
K W Kwan1 Department of Mechanical Engineering, The University of Hong Kong , Hong Kong SAR , People's Republic of China.
K C Ngan2 Department of Clinical Oncology, Queen Elizabeth Hospital , Hong Kong SAR , People's Republic of China.
K H Wong2 Department of Clinical Oncology, Queen Elizabeth Hospital , Hong Kong SAR , People's Republic of China.
Y Tan4 Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University , Hong Kong SAR , People's Republic of China.
S Yao3 Department of Mechanical and Aerospace Engineering, Hong Kong University of Science and Technology , Hong Kong SAR , People's Republic of China.
H Jiang5 Department of Modern Mechanics, University of Science and Technology of China , Hefei , People's Republic of China.
Z Gu6 Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University , Hong Kong SAR , People's Republic of China.
Y Lin1 Department of Mechanical Engineering, The University of Hong Kong , Hong Kong SAR , People's Republic of China.
Queen Elizabeth Hospital · CNUniversity of Hong Kong · HKHong Kong University of Science and Technology · HKHong Kong Baptist University · HKHong Kong Polytechnic University · HKUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have developed a novel electro-osmotic microfluidic system to apply precisely controlled osmolarity gradients to cancer cells in micro-channels. We observed that albeit adhesion is not required for cells to migrate in such a confined microenvironment, the migrating velocity of cells is strongly influenced by the interactions between the cells and the channel wall, with a stronger adhesion leading to diminished cell motility. Furthermore, through examining more than 20 different types of cancer cells, we found a linear positive correlation between the protein concentration of the aquaporin-4 (AQP4) and the cell migrating speed. Knockdown of AQP4 in invasive re-populated cancer stem cells reduced their migration capability down to the level that is comparable to their parental cancer cells. Interestingly, these observations can all be quantitatively explained by the osmotic engine model where the cell movement is assumed to be driven by cross-membrane ion/water transport, while adhesion acts as a frictional resistance against the cell motility. By providing versatile and controllable features in regulating and characterizing the migration capability of cells, our system may serve as a useful tool in quantifying how cell motility is influenced by different physical and biochemical factors, as well as elucidating the mechanisms behind, in the future.

Indexed as

Cell MovementLab-On-A-Chip DevicesModels, BiologicalOsmosisAquaporin 4Extracellular MatrixHumansIon TransportMicrofluidic Analytical TechniquesNeoplasm ProteinsNeoplasmsAQP4 protein, humanAquaporin 4Neoplasm Proteinscancer cellscell adhesioncell motilitywater channel protein

Identifiers

PMID31164075
PMCPMC6597772
OpenAlexW2948814428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.